Cargando…

Monitoring serum HER2 levels in breast cancer patients

BACKGROUND: We have developed a new approach to reduce the serum interference for ELISA. The purpose of this study is to investigate if we can use the optimized ELISA (MBB-ELISA) to detect serum soluble HER2/neu (sHER2) in early stage primary breast cancer and monitor its change during treatments. F...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tchou, Julia, Lam, Lian, Li, Yun Rose, Edwards, Claire, Ky, Bonnie, Zhang, Hongtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Short Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456592/ https://www.ncbi.nlm.nih.gov/pubmed/26069876 http://dx.doi.org/10.1186/s40064-015-1015-6

Ejemplares similares

Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy
por: Arai, Roberto J., et al.
Publicado: (2018)

Interference-Free HER2 ECD as a Serum Biomarker in Breast Cancer
por: Lam, Lian, et al.
Publicado: (2014)

Evaluation of serum Amphiregulin levels in breast cancer patients and cancer-free controls
por: Peterson, Esther A, et al.
Publicado: (2013)

Serum Müllerian inhibiting substance levels are lower in premenopausal women with breast precancer and cancer
por: McCoy, Andrew C, et al.
Publicado: (2011)

Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay
por: Desai, Neelam V., et al.
Publicado: (2018)

Serum HER2 Level Measured by Dot Blot: A Valid and Inexpensive Assay for Monitoring Breast Cancer Progression
por: Tan, Li-Duan, et al.
Publicado: (2011)

ASCO 2018: highlights in HER2-positive metastatic breast cancer
por: Bartsch, Rupert, et al.
Publicado: (2018)

Bevacizumab based chemotherapy in first line treatment of HER2 negative metastatic breast cancer: results of a Moroccan observational institutional study
por: Boulaamane, Lamiaa, et al.
Publicado: (2012)

Effect of body mass index on response to neo-adjuvant therapy in HER2-positive breast cancer: an exploratory analysis of the NeoALTTO trial
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Monitoring Value of Serum HER2 as a Predictive Biomarker in Patients with Metastatic Breast Cancer
por: Zhang, Pengyu, et al.
Publicado: (2020)

Identification of osteopontin-dependent signaling pathways in a mouse model of human breast cancer
por: Mi, Zhiyong, et al.
Publicado: (2009)

Serum EGF-receptor and HER-2 extracellular domains and prognosis of non-small-cell lung cancer
por: Jacot, W, et al.
Publicado: (2004)

Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection
por: Yorozu, Keigo, et al.
Publicado: (2022)

Serum calcium levels are not associated with coronary heart disease
por: Jin, Yuelong, et al.
Publicado: (2013)

Preoperative serum HER2 extracellular domain levels in primary invasive breast cancer
por: Lee, Sae Byul, et al.
Publicado: (2014)

SABCS 2020: update on triple-negative and metastatic HER2-positive breast cancer
por: Bartsch, Rupert
Publicado: (2021)

Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trial
por: Rossi, Lorenzo, et al.
Publicado: (2019)

Correlation between tear fluid and serum vitamin D levels
por: Sethu, Swaminathan, et al.
Publicado: (2016)

Bronchiolitis obliterans organizing pneumonia (BOOP) after thoracic radiotherapy for breast carcinoma
por: Cornelissen, Robin, et al.
Publicado: (2007)

5-Carboxylcytosine levels are elevated in human breast cancers and gliomas
por: Eleftheriou, Maria, et al.
Publicado: (2015)

Prognostic Value of the Serum HER2 Extracellular Domain Level in Breast Cancer: A Systematic Review and Meta-Analysis
por: Wu, Yun, et al.
Publicado: (2022)

Investigation of the serum levels of anterior pituitary hormones in male children with autism
por: Iwata, Keiko, et al.
Publicado: (2011)

Successful treatment of thyrotoxicosis is accompanied by a decrease in serum sclerostin levels
por: Skowrońska-Jóźwiak, Elżbieta, et al.
Publicado: (2012)

Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer
por: Kim, Yun Gyoung, et al.
Publicado: (2017)

Serum amyloid A levels and alpha 2 and gamma globulins on serum protein electrophoresis in cats exposed to and infected with Leishmania infantum
por: Savioli, Giulia, et al.
Publicado: (2021)

Enhertu (Fam-trastuzumab-deruxtecan-nxki) – Revolutionizing treatment paradigm for HER2-Low breast cancer
por: Siddiqui, Tasmiyah, et al.
Publicado: (2022)

Koalas vaccinated against Koala retrovirus respond by producing increased levels of interferon-gamma
por: Olagoke, Olusola, et al.
Publicado: (2020)

Acute TSH stimulation in vivo does not alter serum PCSK9 levels
por: Gagnon, AnneMarie, et al.
Publicado: (2014)

Development of Electrochemical Immunosensors for HER-1 and HER-2 Analysis in Serum for Breast Cancer Patients
por: Wignarajah, Shayalini, et al.
Publicado: (2023)

Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy
por: Dama, Paola, et al.
Publicado: (2019)

HER2+ breast cancer treatment and cardiotoxicity: monitoring and management
por: Jerusalem, Guy, et al.
Publicado: (2019)

A Patient with Cancer and Her Family in Caring Partnership Based on Margaret Newman's Theory of Health as Expanding Consciousness
por: Fujiwara, Yoshimi, et al.
Publicado: (2017)

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab
por: Cizkova, M, et al.
Publicado: (2013)

First line chemotherapy plus trastuzumab in metastatic breast cancer HER2 positive - Observational institutional study
por: Aitelhaj, Meryem, et al.
Publicado: (2016)

CDK 4/6 inhibitors mired in uncertainty in HR positive and HER2 negative early breast cancer
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Hepatitis E Virus infection in HIV-infected patients with elevated serum transaminases levels
por: Sellier, Pierre, et al.
Publicado: (2011)

Prevalent levels of RSV serum neutralizing antibodies in healthy adults outside the RSV-season
por: Van Der Plas, Johan L., et al.
Publicado: (2019)

Co-medication with disulfiram markedly increased serum clozapine levels: Two case reports
por: Hahl-Häkkinen, Lydia, et al.
Publicado: (2023)

Impact of Serum HER2 Levels on Survival and Its Correlation with Clinicopathological Parameters in Women with Breast Cancer
por: Ryu, Dong Won, et al.
Publicado: (2012)

Diagnostic value of serum HER2 levels in breast cancer: a systematic review and meta-analysis
por: Shamshirian, Amir, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d2ncfsfv7h4oe65os8jb72cj1t